Ahmad-Nejad Parviz, Ashavaid Tester, Vacaflores Salinas Aldo, Huggett Jim, Harris Kathryn, Linder Mark W, Baluchova Katarina, Steimer Werner, Payne Deborah A
Institute for Medicine Laboratory Diagnostics, Centre for Clinical and Translational Research (CCTR), HELIOS University Hospital, Wuppertal, Witten/Herdecke University, Germany.
Department of Laboratory Medicine, P.D. Hinduja National Hospital and Medical Research Center, Mumbai, India.
Clin Chim Acta. 2021 Aug;519:239-246. doi: 10.1016/j.cca.2021.05.004. Epub 2021 May 8.
The development and performance of molecular genetic assays has required increasingly complex quality assurance in recent years and continues to pose new challenges. Quality management officers, as well as academic and technical personnel are confronted with new molecular genetic parameters, methods, changing regulatory environments, questions regarding appropriate validation, and quality control for these innovative assays that are increasingly applying quantification and/or multiplex formats. Yet, quality assurance and quality control guidelines are still not widely available or in some circumstances have become outdated. For these reasons, the need for solutions to provide test confidence continues to grow. In order to integrate new test procedures into existing quality assurance measures, the ISO 15189 guideline can serve as an orientation. The ISO 15189 guideline describes requirements for medical laboratories and thus includes those performing molecular diagnostics. This article gives an overview of the possibilities and challenges in quality assurance of molecular parameters and shows possible solutions.
近年来,分子遗传学检测的发展和性能要求越来越复杂的质量保证,并且继续带来新的挑战。质量管理官员以及学术和技术人员面临着新的分子遗传学参数、方法、不断变化的监管环境、有关适当验证的问题以及这些越来越多地采用定量和/或多重检测形式的创新检测的质量控制。然而,质量保证和质量控制指南仍然没有广泛可用,或者在某些情况下已经过时。由于这些原因,提供检测可信度的解决方案的需求持续增长。为了将新的检测程序纳入现有的质量保证措施,ISO 15189指南可以作为一个指导。ISO 15189指南描述了医学实验室的要求,因此包括那些进行分子诊断的实验室。本文概述了分子参数质量保证中的可能性和挑战,并展示了可能的解决方案。